Related Experiment Video
Updated: Jul 22, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
The Efficacy of Directional Atherectomy Prior to Stent Implantation
1Lenox Hill Heart and Vascular Institute, Department of Interventional Cardiology, 130 E. 77th Street, 9th Floor, New York, NY 10021, USA. Imoussa@worldnet.att.net
Insights
Directional atherectomy before coronary stenting may reduce restenosis in complex lesions. Further research and device improvements are needed to confirm its clinical use and safety for specific patient groups.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Background:
- Coronary stents improve outcomes but can lead to in-stent restenosis, particularly in complex lesions.
- High plaque burden is a key factor inciting neointimal proliferation post-stenting.
- In-stent restenosis remains a significant challenge in coronary interventions.
Purpose of the Study:
- To evaluate plaque removal using directional atherectomy before stenting as a strategy to reduce in-stent restenosis.
- To identify patient subgroups and lesion characteristics that may benefit most from this approach.
- To outline requirements for the clinical adoption of directional atherectomy in complex coronary interventions.
Main Methods:
- Review of prospective nonrandomized experience with directional atherectomy and stenting.
- Analysis of factors contributing to neointimal proliferation and restenosis.
- Identification of criteria for patient selection and procedural optimization.
Main Results:
- Prospective nonrandomized data suggest directional atherectomy prior to stenting is a promising approach for selected patients.
- Plaque burden is a recognized factor influencing neointimal proliferation.
- Randomized trial results are pending to establish definitive proof of concept.
Conclusions:
- Directional atherectomy shows potential for reducing restenosis in complex coronary lesions.
- Clinical utility depends on device improvements, minimizing procedural complications (e.g., myocardial infarction), and patient selection.
- High-risk patients with specific lesion types (e.g., noncalcified, large vessels, long/multiple stents, aorto-ostial, bifurcations, CTOs) may be ideal candidates.
Abstract:
Coronary stents have improved the short- and long-term outcomes of patients undergoing catheter-based coronary interventions. However, the use of these devices in complex coronary lesions has also created an incessant form of in-stent restenosis that still defies treatment. Plaque burden has been consistently and reproducibly recognized as an important factor that may incite neointimal proliferation after stent implantation. Prospective nonrandomized experience has shown that plaque removal prior to stent implantation using directional atherectomy is a promising approach to reduce restenosis in selected patients. However, the proof of concept awaits the results of the randomized trials. Ultimately, the clinical use (safety and efficacy) of this approach will depend on 1) further improvements on the current directional atherectomy device to make it user friendly; 2) minimizing the incidence of non-Q-wave myocardial infarction with selective use of IIb-IIIa platelet receptor antagonists or distal protection devices; and 3) targeting patients at high risk for restenosis in whom efficient debulking is feasible. This would include patients who have noncalcified lesions in vessels greater than 2.75 mm but less than 3.5 mm in diameter that require a long stent or multiple stents, aorto-ostial lesions, bifurcational lesions, and chronic total occlusions.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care

